Mia Furebring

761 total citations
26 papers, 314 citations indexed

About

Mia Furebring is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Mia Furebring has authored 26 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 8 papers in Pharmacology and 6 papers in Infectious Diseases. Recurrent topics in Mia Furebring's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Pneumonia and Respiratory Infections (7 papers) and Sepsis Diagnosis and Treatment (6 papers). Mia Furebring is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Pneumonia and Respiratory Infections (7 papers) and Sepsis Diagnosis and Treatment (6 papers). Mia Furebring collaborates with scholars based in Sweden, Italy and Denmark. Mia Furebring's co-authors include Jan Sjölin, Karl Michaëlsson, Rolf Gedeborg, Per Venge, Lena Håkansson, Miklós Lipcsey, Erik Eliasson, Bo Nilsson, Anders Larsson and Sten Rubertsson and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Mia Furebring

24 papers receiving 312 citations

Peers

Countries citing papers authored by Mia Furebring

Since Specialization

Citations

This map shows the geographic impact of Mia Furebring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mia Furebring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mia Furebring more than expected).

Fields of papers citing papers by Mia Furebring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mia Furebring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mia Furebring. The network helps show where Mia Furebring may publish in the future.

Co-authorship network of co-authors of Mia Furebring

This figure shows the co-authorship network connecting the top 25 collaborators of Mia Furebring. A scholar is included among the top collaborators of Mia Furebring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mia Furebring. Mia Furebring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Utilizing gentamicin concentrations to estimate glomerular filtration rate in intensive care unit patients 2025 ·Scientific Reports ·(unknown), (unknown), Elisabet I. Nielsen, Mia Furebring, Anders Larsson, Miklós Lipcsey	0
2	Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study 2025 ·The Lancet Microbe ·(unknown), Sofia Jönsson, (unknown), Karin Hjort, Hervé Nicoloff, Mia Furebring, Dan I. Andersson	5
3	Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort 2025 ·Journal of Antimicrobial Chemotherapy ·(unknown), (unknown), Mia Furebring, Christian G. Giske, Siv Jönsson, Miklós Lipcsey, Elisabet I. Nielsen	0
4	Antifungal Therapy in Candida Infective Endocarditis: A Comparison of Echinocandins and Other Treatment Regimens in a Nationwide Cohort Study 2025 ·Clinical Infectious Diseases ·Siri Kurland, Mia Furebring, Elisabeth Löwdin, Lars Olaison, Jan Sjölin	1
5	Model-informed precision dosing of vancomycin in clinical practice: an intervention development study 2024 ·International Journal of Clinical Pharmacy ·(unknown), Anna‐Karin Hamberg, Mia Furebring, Thomas Tängdén, Elisabet I. Nielsen	2
6	Swedish multicentre study of target attainments with β-lactams in the ICU: which MIC parameter should be used? 2023 ·Journal of Antimicrobial Chemotherapy ·(unknown), Mia Furebring, Miklós Lipcsey, Christian G. Giske	4
7	Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient 2022 ·Medical Mycology Case Reports ·Amelie Kinch, Mia Furebring, Erja Chryssanthou, Heléne Hallböök	1
8	Low attainment to PK/PD-targets for β-lactams in a multi-center study on the first 72 h of treatment in ICU patients 2022 ·Scientific Reports ·(unknown), Mia Furebring, Erik Eliasson, Miklós Lipcsey	12
9	Population pharmacokinetics of cefotaxime in intensive care patients 2021 ·European Journal of Clinical Pharmacology ·(unknown), (unknown), Mia Furebring, Miklós Lipcsey, Siv Jönsson, Elisabet I. Nielsen	7
10	Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill? 2021 ·Mycoses ·Siri Kurland, Elisabeth Löwdin, Mia Furebring, (unknown), Erja Chryssanthou, Pernilla Lagerbäck, Thomas Tängdén, Olof Breuer, Jan Sjölin	3
11	Aortic Graft Infections – A Nationwide Study 2019 ·European Journal of Vascular and Endovascular Surgery ·(unknown), Mia Furebring, Kevin Mani, Anders Wanhainen	1
12	Nationwide Study of the Treatment of Mycotic Abdominal Aortic Aneurysms Comparing Open and Endovascular Repair 2017 ·Journal of Vascular Surgery ·Karl Sörelius, Anders Wanhainen, Mia Furebring, (unknown), Peter Gillgren, Kevin Mani	1
13	Rational use of aminoglycosides—Review and recommendations by the Swedish Reference Group for Antibiotics (SRGA) 2012 ·Scandinavian Journal of Infectious Diseases ·Håkan Hanberger, Charlotta Edlund, Mia Furebring, Christian G. Giske, Åsa Melhus, Lennart Nilsson, Johan Petersson, Jan Sjölin, Anders Ternhag, M. Werner, Erik Eliasson, (unknown)	43
14	Neurointensive care of patients with severe community-acquired meningitis 2011 ·Acta Anaesthesiologica Scandinavica ·(unknown), Mia Furebring, Jan Sjölin, Per Enblad	23
15	Significant differences when using creatinine, modification of diet in renal disease, or cystatin C for estimating glomerular filtration rate in ICU patients 2010 ·Upsala Journal of Medical Sciences ·Miklós Lipcsey, Mia Furebring, Sten Rubertsson, Anders Larsson	26
16	Diagnosis-dependent misclassification of infections using administrative data variably affected incidence and mortality estimates in ICU patients 2006 ·Journal of Clinical Epidemiology ·Rolf Gedeborg, Mia Furebring, Karl Michaëlsson	69
17	C5a, Interleukin‐8 and Tumour Necrosis factor‐α‐Induced Changes in Granulocyte and Monocyte Expression of Complement Receptors in Whole Blood and on Isolated Leukocytes 2006 ·Scandinavian Journal of Immunology ·Mia Furebring, Lena Håkansson, Per Venge, Jan Sjölin	12
18	Differential Expression of the C5a Receptor and Complement Receptors 1 and 3 after LPS Stimulation of Neutrophils and Monocytes 2004 ·Scandinavian Journal of Immunology ·Mia Furebring, Lena Håkansson, Per Venge, Jan Sjölin	12
19	Subcellular localization and mobilization of carcinoembryonic antigen‐related cell adhesion molecule 8 in human neutrophils 2004 ·British Journal of Haematology ·Linshu Zhao, Mia Furebring, Shengyuan Xu, Per Venge	15
20	Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis 2002 ·Critical Care ·Mia Furebring, Lena Håkansson, Per Venge, Bo Nilsson, Jan Sjölin	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact